BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 11271299)

  • 1. A retrospective flow cytometric crossmatch study in transplant recipients with autoreactive lymphocytotoxic antibodies.
    Martin S; Davies MS; Robson AJ
    Transpl Int; 1994; 7 Suppl 1():S527-31. PubMed ID: 11271299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The association between a positive T and B cell flow cytometry crossmatch and renal transplant failure.
    Martin S; Liggett H; Robson A; Connolly J; Johnson RW
    Transpl Immunol; 1993; 1(4):270-6. PubMed ID: 8081783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Weak humoral posttransplant alloresponse after a well-HLA-matched cadaveric kidney transplantation.
    Matinlauri IH; Kyllönen LE; Eklund BH; Koskimies SA; Salmela KT
    Transplantation; 2004 Jul; 78(2):198-204. PubMed ID: 15280678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Persistence of low levels of alloantibody after desensitization in crossmatch-positive living-donor kidney transplantation.
    Gloor JM; DeGoey S; Ploeger N; Gebel H; Bray R; Moore SB; Dean PG; Stegall MD
    Transplantation; 2004 Jul; 78(2):221-7. PubMed ID: 15280682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The flow cytometric crossmatch and early renal transplant loss.
    Mahoney RJ; Ault KA; Given SR; Adams RJ; Breggia AC; Paris PA; Palomaki GE; Hitchcox SA; White BW; Himmelfarb J
    Transplantation; 1990 Mar; 49(3):527-35. PubMed ID: 2138366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Flow cytometric crossmatching in primary renal transplant recipients with a negative anti-human globulin enhanced cytotoxicity crossmatch.
    Karpinski M; Rush D; Jeffery J; Exner M; Regele H; Dancea S; Pochinco D; Birk P; Nickerson P
    J Am Soc Nephrol; 2001 Dec; 12(12):2807-2814. PubMed ID: 11729251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytotoxic flow cytometric crossmatch in renal transplantation: a single assay to simultaneously detect antibody binding and cytotoxicity.
    Thammanichanond D; Athimang W; Paisooksantivatana K; Mongkolsuk T; Ingsathit A; Worawichawong S; Kitpoka P; Jirasiritham S; Kantachuvesiri S
    Transplant Proc; 2012 Jan; 44(1):62-5. PubMed ID: 22310580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of correlation between IgG T-lymphocyte flow cytometric crossmatches with primary renal allograft outcome.
    Evans PR; Lane AC; Lambert CM; Reynolds WM; Wilson PJ; Harris KR; Slapak M; Lee HA; Smith JL
    Transpl Int; 1992; 5 Suppl 1():S609-12. PubMed ID: 14621889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Living-Donor Kidney Transplant With Preformed Donor-Specific Antibodies.
    Itabashi Y; Aikawa A; Muramatsu M; Hyoudou Y; Shinoda K; Takahashi Y; Sakurabayashi K; Mizutani T; Oguchi H; Arai T; Kawamura T; Hamasaki Y; Sakai K; Shishido S
    Exp Clin Transplant; 2019 Jan; 17(Suppl 1):43-49. PubMed ID: 30777522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The flow cytometry crossmatch in kidney transplantation.
    Cook DJ; Terasaki PI; Iwaki Y; Terashita G; Takeda A; Fujikawa J; Lau M; Danovitch G; Rosenthal JT; Fine R
    Clin Transpl; 1987; ():409-14. PubMed ID: 3154440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The significance of a positive flow cytometry crossmatch test in primary kidney transplantation.
    Ogura K; Terasaki PI; Johnson C; Mendez R; Rosenthal JT; Ettenger R; Martin DC; Dainko E; Cohen L; Mackett T
    Transplantation; 1993 Aug; 56(2):294-8. PubMed ID: 8356583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relevance of posttransplant flow cytometric T- and B-cell crossmatches in tacrolimus-treated renal transplant patients.
    Lenaers JI; Christiaans MH; Voorter CE; van Hooff HP; van den Berg-Loonen EM
    Transplantation; 2006 Nov; 82(9):1142-7. PubMed ID: 17102764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical implications of flow cytometry crossmatch with T or B cells in living donor liver transplantation.
    Takakura K; Kiuchi T; Kasahara M; Uryuhara K; Uemoto S; Inomata Y; Tanaka K
    Clin Transplant; 2001 Oct; 15(5):309-16. PubMed ID: 11678956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of positive B cell flow cytometry crossmatch in predicting rejection among renal transplant recipients.
    Kotb M; Russell WC; Hathaway DK; Gaber LW; Gaber AO
    Clin Transplant; 1999 Feb; 13(1 Pt 2):83-9. PubMed ID: 10081642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of flow cytometry-detected IgG and IgM anti-donor antibodies in cardiac allograft recipients.
    Przybylowski P; Balogna M; Radovancevic B; Frazier OH; Susskind B; Van Buren C; Katz S; Kahan BD; Kerman R
    Transplantation; 1999 Jan; 67(2):258-62. PubMed ID: 10075590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modified flow cytometry crossmatch detecting alloantibody-related cytotoxicity as a way to distinguish lytic antibodies from harmless in allosensitised kidney recipients.
    Zieliński M; Zielińska H; Moszkowska G; Dȩbska-Ślizień A; Rutkowski B; Trzonkowski P
    Transplant Proc; 2013; 45(1):88-94. PubMed ID: 23375279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Living-donor kidney transplant in T-cell and B-cell flow cytometry crossmatch-positive patients.
    Terasaka S; Kitada H; Okabe Y; Kawanami S; Noguchi H; Miyamoto K; Tsuchimoto A; Masutani K; Tanaka M
    Exp Clin Transplant; 2014 Jun; 12(3):227-32. PubMed ID: 24907723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The flow cytometric crossmatch. Dual-color analysis of T cell and B cell reactivities.
    Bray RA; Lebeck LK; Gebel HM
    Transplantation; 1989 Nov; 48(5):834-40. PubMed ID: 2815255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kidney transplant monitoring by anti donor specific antibodies.
    Torlone N; Piazza A; Valeri M; Monaco PI; Provenzani L; Poggi E; Adorno D; Casciani CU
    Transpl Int; 1992; 5 Suppl 1():S676-8. PubMed ID: 14621907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of patients at risk for inferior renal allograft outcome by a strongly positive B cell flow cytometry crossmatch.
    Lazda VA
    Transplantation; 1994 Mar; 57(6):964-9. PubMed ID: 8154047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.